Skip to main content
. 2019 Nov 13;20(3):223–228. doi: 10.1007/s40256-019-00382-0

Fig. 1.

Fig. 1

Plasma anti-factor Xa (anti-Xa) activity over a 10-day treatment period according to creatinine clearance (CrCl) value in patients receiving treatment doses of tinzaparin of 175 IU/kg once daily. IU international units

(adapted from Siguret et al. [19])